Drug Shortage Report for DANTRIUM INTRAVENOUS
| Report ID | 166508 |
| Drug Identification Number | 01997572 |
| Brand name | DANTRIUM INTRAVENOUS |
| Common or Proper name | DANTROLENE SODIUM |
| Company Name | ENDO PAR INNOVATION COMPANY, LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | DANTROLENE SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 6x20mg Vials |
| ATC code | M03CA |
| ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-20 |
| Estimated end date | 2022-11-04 |
| Actual end date | 2022-12-21 |
| Shortage status | Resolved |
| Updated date | 2022-12-23 |
| Company comments | Limited quantity available on allocation under October, distributed by Paladin Labs PaladinCS@endo.com |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6 RAM RIDGE ROAD CHESTNUT RIDGE, NEW YORK UNITED STATES 10977 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-12-23 | French | Compare |
| v7 | 2022-12-23 | English | Compare |
| v6 | 2022-10-06 | French | Compare |
| v5 | 2022-10-06 | English | Compare |
| v4 | 2022-08-11 | French | Compare |
| v3 | 2022-08-11 | English | Compare |
| v2 | 2022-08-11 | French | Compare |
| v1 | 2022-08-11 | English | Compare |
Showing 1 to 8 of 8